Cutler, David M. Are the Benefits of Medicine Worth What We Pay for It? 15th Annual Herbert Lourie Memorial Lecture on Health Policy. Center for Policy Research Briefs. 2004; 27. http://ideas.repec.org/p/max/cprpbr/27.html
Ischemic stroke patients treated with t-PA (a drug used to treat blood clots) within 3 hours of onset are 33% more likely to be free of disability 3 months after… [ Get More Details ]
Several prevention/early detection interventions for cardiovascular disease have cost-effectiveness ratios of $50,000-$70,000 per life saved.
[ Get More Details ]
TAVR v. SAVR in Intermediate-Risk SAS Patients
At 1-year, severe aortic stenosis (SAS) patients with intermediate surgical mortality risk who underwent transcatheter aortic valve replacement (TAVR), had all-cause mortality rates of 7.4% (compared to 13% for surgical… [ Get More Details ]
“Increasing life expectancy in western society is a result of two major success stories in the prevention and treatment of human disease. The first milestone was eliminating the scourge of… [ Get More Details ]
Compared to predicted levels in the absence of drug therapy, there were 9% fewer deaths from major cardiovascular disease in 2001 and 38% and 25% fewer hospital discharges for stroke… [ Get More Details ]